Skip to main content

Month: September 2025

ESH Acquisition Corp. and The Original Fit Factory, Ltd. Announce the Execution of a Business Combination Agreement

Upon the closing of the proposed transaction, the combined company will become a US-domiciled, public company ready to advance its ecosystem of health and wellness digital platforms, connected devices, and premium fitness studios. The proposed transaction with ESH Acquisition Corp. values The Original Fit Factory, Ltd. at an implied pro-forma equity value of $500 million. New York, New York, Sept. 15, 2025 (GLOBE NEWSWIRE) — ESH Acquisition Corp. (NASDAQ: ESHA) (“ESH”), a publicly traded special purpose acquisition company, and The Original Fit Factory, Ltd. (“The Original Fit Factory”), a next-generation health and wellness group, today announced that they have entered into a definitive business combination agreement (the “Business Combination Agreement”). The proposed transaction reflects an implied pro-forma equity valuation...

Continue reading

Bright Green Corporation Merges with PharmAGRI Capital Partners; Lynn Stockwell Appointed CEO and Chairwoman

Tesla Robotics to Power Sovereign “Seed to Syringe” Pharmaceutical Infrastructure Fort Lauderdale, FL, Sept. 15, 2025 (GLOBE NEWSWIRE) — Bright Green Corporation (OTC: BGXX) has announced its merger with PharmAGRI Capital Partners, a federally aligned pharmaceutical infrastructure platform architected to restore U.S. drug manufacturing sovereignty. The transaction consolidates BGXX’s DEA registrations, Board of Pharmacy licensure, audited financials, and Nasdaq history into PharmAGRI under a court-supervised restructuring plan filed in the District of New Mexico. Effective immediately, Lynn Stockwell has been appointed Chief Executive Officer and Chairwoman of PharmAGRI. Ms. Stockwell will appoint a new board composed of directors from her Drugs Made In America Acquisition Corps—a series of four Nasdaq-listed special purpose acquisition...

Continue reading

Paladin Announces A$300 Million Fully Underwritten Equity Raising to Advance the PLS Project

Not for release to US newswire services or distribution in the United States PERTH, Australia, Sept. 15, 2025 (GLOBE NEWSWIRE) — Paladin Energy Ltd (ASX:PDN, TSX:PDN, OTCQX:PALAF) (Paladin or the Company) announces it has launched a fully underwritten equity raising, comprising (i) an A$231 million ASX institutional placement of new Paladin fully paid ordinary shares (Shares) (ASX Placement), (ii) a Canadian “bought deal” private placement to raise C$30 million (~A$33 million) pursuant to the Listed Issuer Financing Exemption (as defined herein) (TSX Bought Deal), and (iii) a fully underwritten sale of ~A$36 million of existing Shares issued and subsequently acquired as a result of the acquisition of Fission Uranium Corp. (Fission) (Treasury Share Sale), to raise a total amount of A$300 million (together, the Offer).1 Additionally,...

Continue reading

EnviroGold Announces Non-Brokered Private Placement to Accelerate Growth

VANCOUVER, British Columbia, Sept. 15, 2025 (GLOBE NEWSWIRE) — EnviroGold Global Limited (CSE: NVRO | OTCQB: ESGLF | FSE: YGK), (“EnviroGold,” or the “Company”), a clean technology company transforming mine waste into high-value metals, is pleased to announce a proposed non-brokered private placement (the “Offering”). The Company intends to raise gross proceeds of up to $5 million through the issuance of units of the Company (“Units” and each, a “Unit”) at a price of C$0.09 per Unit. Each Unit will consist of one common share of the Company and one transferable common share purchase warrant (each, a “Warrant”). Each Warrant will entitle the holder to acquire one additional common share of the Company at a price of C$0.13 for a period of three years from the closing date of the tranche in which the Unit is issued. The Company has...

Continue reading

People taking Novo Nordisk’s Wegovy® experienced reduced food noise and boosted mental well-being

Results from a real-world survey suggest that semaglutide for weight management (Wegovy®) helped suppress food noise – unwanted and intrusive thoughts about food – in addition to its established effect on weight loss1 The number of people who reported experiencing constant thoughts about food throughout the day declined by 46% after starting treatment with Wegovy®1 The majority of respondents reported improved mental health (64%) and healthier habits (80%) while taking Wegovy®1Bagsværd, Denmark, 16 September 2025 – Novo Nordisk today announced results from the US-based INFORM survey of people taking semaglutide for weight management (Wegovy®), at the European Association for the Study of Diabetes (EASD) 2025, Vienna, Austria. The INFORM survey revealed that individuals experienced a substantial drop in food noise after starting Wegovy®...

Continue reading

VitalHub Announces Change of Auditor

TORONTO, Sept. 15, 2025 (GLOBE NEWSWIRE) — Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today that it has changed its auditor from MNP LLP (the “Former Auditor”) to Ernst & Young LLP (the “Successor Auditor”) effective September 9, 2025. At the request of the Company, the Former Auditor resigned as the auditor of the Company and the Board of Directors of the Company appointed the Successor Auditor as the new auditor effective September 9, 2025, until the close of the Company’s next Annual General Meeting. There were no reservations in the Former Auditor’s audit reports in connection with the two most recently completed fiscal years. There are no reportable events (as the term is defined in National Instrument 51-102 – Continuous Disclosure Obligations) between the Company...

Continue reading

Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne

Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne IRVINE, CA, and HERSTAL, BELGIUM – September 15, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the “Company” or “mdxhealth”), a leading precision diagnostics company, today announced the closing of the ExoDx business acquisition from Bio-Techne Corporation, which includes the ExoDx Prostate test. Acquisition of ExoDx Business On August 5, 2025, mdxhealth signed a definitive agreement to acquire Exosome Diagnostics, Inc. from Bio-Techne, including the ExoDx Prostate (EPI) test, CLIA-certified clinical laboratory and related assets. Total consideration for the acquisition is $15 million, with $5 million in stock paid at closing and $2.5 million to be paid annually over the following 4 years with 50% in cash and 50% in cash or stock...

Continue reading

Churchill Downs Incorporated 2025 Third Quarter Financial Results Conference Call Invitation

LOUISVILLE, Ky., Sept. 15, 2025 (GLOBE NEWSWIRE) — Churchill Downs Incorporated (“CDI” or “the Company”) announced today that the Company will release third quarter 2025 financial results after the market closes on Wednesday, October 22, 2025, and host a related conference call to discuss the quarter on Thursday, October 23, 2025, at 8 a.m. ET. Investors and other interested parties may listen to the call by accessing the online, real-time webcast at http://ir.churchilldownsincorporated.com/events.cfm or by registering in advance via teleconference here. Once registration is completed, participants will be provided with a dial-in number containing a personalized conference code to access the call. All participants are encouraged to dial-in 15 minutes prior to the start time. An online replay of the call will be available at http://ir.churchilldownsincorporated.com/events.cfm...

Continue reading

Bombardier Announces 2024 Winners of its Supplier Recognition Program

Bombardier’s Supplier Recognition Program now includes three new award categories — Environmental Sustainability, Quality, and Outstanding Partnership. Winners in these categories will be honored alongside recipients of the prestigious Diamond Award Awards are granted to suppliers who have demonstrated outstanding performance in 2024 With the renewal of this program, Bombardier is proud to continue its longstanding tradition of recognizing suppliers for their commitment to excellence  Bombardier presented the awards to suppliers during a ceremony held in Montreal on September 15, 2025MONTREAL, Sept. 15, 2025 (GLOBE NEWSWIRE) — Bombardier is proud to announce the recipients of its Supplier Recognition Program for 2024, which now recognizes the contributions of suppliers in four distinct categories: Diamond, Environmental Sustainability,...

Continue reading

ERES Provides Update on Previously Disclosed Strategic Dispositions, Declares Special Distribution and Cessation of Monthly Distribution

TORONTO, Sept. 15, 2025 (GLOBE NEWSWIRE) — European Residential Real Estate Investment Trust (“ERES” or “the REIT”) (TSX:ERE.UN) announced today that, subject to the completion of standard notary procedures, it has closed on the previously announced disposition of entities owning 1,446 residential suites in the Netherlands for aggregate proceeds, net of an adjustment for deferred taxes and other adjustments, of approximately €336 million. ERES further announced that, in addition to having closed on the sale of its commercial property in Brussels, Belgium, it has also completed the previously disclosed disposition of its commercial property in Landshut, Germany, for aggregate gross proceeds of approximately €31 million (all together, the “Closed Dispositions”). Please refer to the REIT’s press releases dated April 2, 2025 and July...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.